Early assessment of treatment response in primary biliary cholangitis: key to timely management
Abstract Aim The aim of our study was to explore predictive factors associated with compete biochemical response (CBR) in primary biliary cholangitis (PBC) patients treated with ursodeoxycholic acid (UDCA) at month 12 and at last check-up; CBR was defined as both normal bilirubin and ALP levels. We...
Saved in:
| Main Authors: | Tomas Koky, Sylvia Drazilova, Martin Janicko, Dominika Toporcerova, Jakub Gazda, Peter Jarcuska |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | BMC Gastroenterology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12876-025-04138-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic scores in primary biliary cholangitis
by: Ramzi Tababi, et al.
Published: (2024-12-01) -
COVID-19 in Patients with Primary Biliary Cholangitis
by: М. К. Prashnova, et al.
Published: (2022-09-01) -
Primary biliary cholangitis
by: I. M. Iljinsky, et al.
Published: (2021-04-01) -
The effectiveness of combining ursodeoxycholic acid with vitamin D in treating patients with primary biliary cholangitis and its impact on hepatic fibrosis: a randomized trial
by: Yilihamu Abulitifu, et al.
Published: (2025-07-01) -
Cholesterol-modified prognostic nutritional index as an independent prognostic biomarker in primary biliary cholangitis patients
by: Huiling Zhu, et al.
Published: (2025-05-01)